LONG-TERM COMPLETE REMISSIONS IN PATIENTS WITH DISSEMINATED MELANOMA TREATED BY FOTEMUSTINE AND DACARBAZINE

被引：10
|
作者：
OLIVER, V
ALIAGA, A
LOPEZ, JJL
PEREZ, E
PONCHON, A
BIZZARI, JP
COUR, V
机构：
[1] INST RECH INT SERVIER,6 PL PLEIADES,F-92415 COURBEVOIE,FRANCE
[2] HOSP SANT PAU,BARCELONA,SPAIN
[3] UNIV VALENCIA,HOSP GEN,VALENCIA,SPAIN
来源：
EUROPEAN JOURNAL OF CANCER | 1993年 / 29A卷 / 02期
关键词：
D O I：
10.1016/0959-8049(93)90198-O
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [41] Long-term outcomes of advanced BRAF-mutated melanoma patients and complete or partial response
    Chatziioannou, E.
    Sinnberg, T.
    Leiter-Stoeppke, U.
    Flatz, L.
    Amaral, T.
    JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 2023, 21 : 75 - 76
  • [42] CYTOGENETIC AND MOLECULAR REMISSIONS IN PATIENTS WITH STABLE PHASE CHRONIC MYELOGENOUS LEUKEMIA TREATED WITH LONG-TERM INTERFERON-ALPHA
    BESA, EC
    ROVITO, MA
    LUCE, M
    NOWELL, PC
    BLOOD, 1994, 84 (10) : A155 - A155
  • [43] Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy
    Lane, Anne Marie
    Kim, Ivana K.
    Gragoudas, Evangelos S.
    JAMA OPHTHALMOLOGY, 2015, 133 (07) : 792 - 796
  • [44] LONG-TERM SECOND REMISSIONS IN ACUTE LYMPHATIC LEUKEMIA
    LEVENTHAL, BG
    LEVINE, AS
    GRAW, RG
    SIMON, R
    FREIREICH, EJ
    HENDERSON, ES
    CANCER, 1975, 35 (04) : 1136 - 1140
  • [45] Metastatic Melanoma: Long-Term but not Durable Complete Remission with BRAF Inhibitor
    La Rosa, P. Zulueta
    Giakoumi, S.
    Beiteke, U.
    Witteler, A.
    Kuegler, K.
    Nashan, D.
    AKTUELLE DERMATOLOGIE, 2016, 42 (8-9) : 340 - 343
  • [46] ACTIVITY AND UNEXPECTED LUNG TOXICITY OF THE SEQUENTIAL ADMINISTRATION OF 2 ALKYLATING-AGENTS - DACARBAZINE AND FOTEMUSTINE IN PATIENTS WITH MELANOMA
    GERARD, B
    AAMDAL, S
    LEE, SM
    LEYVRAZ, S
    LUCAS, C
    DINCALCI, M
    BIZZARI, JP
    EUROPEAN JOURNAL OF CANCER, 1993, 29A (05) : 711 - 719
  • [47] Long-term survivors among patients with metastatic melanoma treated with targeted agents and/or checkpoint inhibitors
    Linardou, H.
    Laskarakis, A.
    Molfeta, A.
    Sakellariou, K.
    Tarampikou, A.
    Soroli, E.
    Gkiati, K.
    Bafaloukos, D.
    ANNALS OF ONCOLOGY, 2018, 29
  • [48] Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade
    Warner, Allison Betof
    Palmer, Jessica S.
    Shoushtari, Alexander N.
    Goldman, Debra A.
    Panageas, Katherine S.
    Hayes, Sara A.
    Bajwa, Raazi
    Momtaz, Parisa
    Callahan, Margaret K.
    Wolchok, Jedd D.
    Postow, Michael A.
    Chapman, Paul B.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15) : 1655 - +
  • [49] Long-term outcome of cutaneous melanoma patients treated with boron neutron capture therapy (BNCT)
    Hiratsuka, Junichi
    Kamitani, Nobuhiko
    Tanaka, Ryo
    Tokiya, Ryoji
    Yoden, Eisaku
    Sakurai, Yosinori
    Suzuki, Minoru
    JOURNAL OF RADIATION RESEARCH, 2020, 61 (06) : 945 - 951
  • [50] Long-Term Survival Shown for Advanced Melanoma Patients Treated with PD-1 Inhibitor
    Printz, Carrie
    CANCER, 2016, 122 (20) : 3100 - 3101
12345